Sign In

Anjali Gopalan, MD, MS

People

Kaiser Permanente Division of Research
2000 Broadway
Oakland, CA 94612


anjali.gopalan@kp.org
Kaiser Permanente Researcher Profiles


Anjali Gopalan, MD, MS, is a research scientist in the Division of Research, Kaiser Permanente Northern California. Dr. Gopalan received her undergraduate degree in biochemistry and biology from Rice University. She completed medical school at Washington University in St. Louis. She then went on to complete an internal medicine residency at the University of Pennsylvania and was a member of the program's primary care track. Following residency she was a Robert Wood Johnson Clinical Scholar at the University of Pennsylvania and earned a Master's degree in Health Policy Research. Her current research interests include the roles of information and communication for patients with chronic disease. Specifically, she is interested in researching alternative, more effective ways to present medical information to patients regarding chronic disease management, particularly diabetes.

Current Position(s):

  • Research Scientist II, Division of Research, Kaiser Permanente Northern California
  • Physician, Kaiser Permanente Oakland Medical Center

Section Affiliations:

Primary Research Interests:

  • Type 2 diabetes and pre-diabetes
  • Patient-provider communication
  • Information and risk presentation strategies
  • Behavioral economics

    Tailoring initial type 2 diabetes care to meet the needs of younger Latinx adults: A randomized pilot study

    Our goal is to evaluate the effectiveness of a proactive, tailored care intervention in improving early outcomes for Latinx individuals with younger-onset type 2 diabetes. We will also conduct post-intervention interviews with study participants to identify components of the intervention that may have contributed to the observed outcomes and perform an environmental scan of type 2 diabetes care and resources in our partner Kaiser Permanente regions to lay the groundwork for future dissemination of the intervention.
    Investigator: Gopalan, Anjali
    Funder: American Diabetes Association

    Tailoring care to meet the needs of younger Latinx adults with newly diagnosed type 2 diabetes

    We will evaluate a culturally responsive community health worker (CHW) intervention targeting younger-onset Latinx individuals with a new type 2 diabetes (T2D) diagnosis (AURORA [Active Outreach to Younger Latinx]). The AURORA strategy centers on a CHW who will proactively conduct three telemedicine visits tailored to with the following five goals: 1) T2D self-management education, 2) assessment of individual’s self-management support needs, 3) motivational interviewing to support behavior change, 4) pragmatic skills training, including use of crucial technologies to support self-management, and 5) matching member's needs with existing KPNC T2D resources.
    Investigator: Gopalan, Anjali
    Funder: Garfield Memorial Fund

    Using predictive analytics to tailor care for patients with newly diagnosed type 2 diabetes

    In a population of adults newly diagnosed with type 2 diabetes (T2D) from 2010-2015 and followed for 5 years this study will use machine learning-based predictive analytic methods to develop and validate predictive models using EHR-derived patient data available at the time of T2D diagnosis to identify patients at increased risk for suboptimal 1-year and 5-year glycemic trends. Secondary predictive models will be developed to identify individuals at increased risk for other adverse T2D-outcomes, including microalbuminuria, microvascular disease, and macrovascular disease. The study will also develop and validate predictive models that include data from the first year following T2D diagnosis to identify patients at increased risk for suboptimal 5-year glycemic trends.
    Investigator: Gopalan, Anjali
    Funder: National Institute of Diabetes and Digestive and Kidney Diseases

    Age- and race/ethnic-based disparities in diabetes outcomes among younger adults with newly diagnosed Type 2 Diabetes

    This study will conduct focus groups with KPNC members (age 45) with newly diagnosed Type 2 diabetes to learn about members’ experiences with this new diagnosis and to identify early facilitators of and barriers to effective diabetes management in this group.
    Investigator: Gopalan, Anjali
    Funder: Northern California Community Benefit Programs

    Metformin Initiation and Early Adherence among Kaiser Permanente Northern California Members with Newly Diagnosed Type 2 Diabetes

    Aim 1: Identify patient-level predictors of metformin treatment during the year following type 2 diabetes diagnosis. Examined factors will include: demographics, such as age, race/ethnicity, gender, and rural versus urban; clinical characteristics, such as A1c at diagnosis, diabetes-related comorbidities (hypertension, renal disease), number/type of other medications used, and gastrointestinal comorbidities (irritable bowel, H. pylori); and other care-related factors, such as medication copays, in-person visit copays, flu vaccination (proxy for openness to traditional treatment approaches), length of Kaiser Permanente Northern California membership, and primary care physician (PCP) contact/empanelment time. Aim 2: Identify provider-level predictors of early metformin treatment during the year following type 2 diabetes diagnosis. Examined factors will include: ordering provider type, such as PCP vs. other medical doctor versus other (e.g., population manager); PCP characteristics, such as PCP-member race concordance, PCP years in practice, and number of type 2 diabetes patients in panel; and primary Kaiser Permanente Northern California facility.
    Investigator: Gopalan, Anjali
    Funder: Northern California Community Benefit Programs

    The Initial Care of Younger Adults with Newly Diagnosed Type 2 Diabetes

    ​In a population of adults with newly diagnosed, early onset type 2 diabetes, this study will identify patient-, provider-, and system-level predictors of inadequate glycemic control within one year following diagnosis. A longitudinal, retrospective cohort analysis of electronic health record data will be conducted to examine associations between select factors and early glycemic control. This study will also explore barriers to and facilitators of type 2 diabetes care; patients and providers will be engaged in a qualitative process to identify barriers and facilitators affecting early diabetes care. Lastly, this project will examine associations between patient-reported factors and early glycemic control. To extend characterization of potentially modifiable care barriers in this population, validated instruments (selected based on existing literature and study findings) will be used to survey a cohort of patients and follow this cohort prospectively for one year to assess relationships between responses and glycemic control.
    Investigator: Gopalan, Anjali
    Funder: National Institute of Diabetes and Digestive and Kidney Diseases
    No results found matching criteria

    Disparities in Use of Video Telemedicine Among Patients With Limited English Proficiency During the COVID-19 Pandemic

    Author(s): Hsueh L; Huang J; Millman AK; Gopalan A; Parikh RK; Teran S; Reed ME

    JAMA Netw Open. 2021 11 01;4(11):e2133129. Epub 2021-11-01.

    PubMed abstract

    Racial and Ethnic Differences in Age at Diabetes Diagnosis-A Call for Action

    Author(s): Gopalan A; Habib AR; Grant RW

    JAMA Intern Med. 2021 Sep 07.

    PubMed abstract

    Updated USPSTF Screening Recommendations for Diabetes: Identification of Abnormal Glucose Metabolism in Younger Adults

    Author(s): Grant RW; Gopalan A; Jaffe MG

    JAMA Intern Med. 2021 Aug 24.

    PubMed abstract

    The Role of Community-Based Organizations in Improving Chronic Care for Safety-Net Populations

    Author(s): Nguyen KH; Fields JD; Cemballi AG; Desai R; Gopalan A; Cruz T; Shah A; Akom A; Brown W; Sarkar U; Lyles CR

    J Am Board Fam Med. 2021 Jul-Aug;34(4):698-708.

    PubMed abstract

    Engaging patients in population-based chronic disease management: A qualitative study of barriers and intervention opportunities

    Author(s): Fang A; Abdelgadir D; Gopalan A; Ross T; Uratsu CS; Sterling SA; Grant RW; Iturralde E

    Patient Educ Couns. 2021 May 04.

    PubMed abstract

    Visit Content Analysis: Doctor-Patient Communication in Patients with Type 2 Diabetes

    Author(s): Abdelgadir DA; Rodriguez LM; Blatchins MA; Mishra P; Gopalan A; Grant RW

    Perm J. 2021 May;25.

    PubMed abstract

    Disclosure of New Type 2 Diabetes Diagnoses to Younger Adults: a Qualitative Study

    Author(s): Gopalan A; Blatchins MA; Altschuler A; Mishra P; Fakhouri I; Grant RW

    J Gen Intern Med. 2021 Jan 26.

    PubMed abstract

    Testing patient-informed approaches for visually depicting the hemoglobin A1c value to patients with poorly controlled diabetes: a randomized, controlled trial

    Author(s): Gopalan A; Suttner L; Troxel AB; McDonough K; Schapira MM

    BMC Health Serv Res. 2020 Mar 06;20(1):178. Epub 2020-03-06.

    PubMed abstract

    Initial Glycemic Control and Care Among Younger Adults Diagnosed With Type 2 Diabetes

    Author(s): Gopalan A; Mishra P; Alexeeff SE; Blatchins MA; Kim E; Man A; Karter AJ; Grant RW

    Diabetes Care. 2020 Mar 04.

    PubMed abstract

    Use and Discontinuation of Insulin Treatment Among Adults Aged 75 to 79 Years With Type 2 Diabetes

    Author(s): Weiner JZ; Gopalan A; Mishra P; Lipska KJ; Huang ES; Laiteerapong N; Karter AJ; Grant RW

    JAMA Intern Med. 2019 Sep 23.

    PubMed abstract

    Use of financial incentives and text message feedback to increase healthy food purchases in a grocery store cash back program: a randomized controlled trial

    Author(s): Gopalan A; Shaw PA; Lim R; Paramanund J; Patel D; Zhu J; Volpp KG; Buttenheim AM

    BMC Public Health. 2019 May 31;19(1):674. Epub 2019-05-31.

    PubMed abstract

    Exploring how patients understand and assess their diabetes control

    Author(s): Gopalan A; Kellom K; McDonough K; Schapira MM

    BMC Endocr Disord. 2018 Nov 06;18(1):79. Epub 2018-11-06.

    PubMed abstract

    Prevalence and predictors of delayed clinical diagnosis of Type 2 diabetes: a longitudinal cohort study

    Author(s): Gopalan A; Mishra P; Alexeeff SE; Blatchins MA; Kim E; Man AH; Grant RW

    Diabet Med. 2018 Sep 03.

    PubMed abstract

    Research to Change Health Delivery Systems: On the Outside Looking in?

    Author(s): Gopalan A; Grant RW

    J Gen Intern Med. 2018 Jul 20.

    PubMed abstract

    Identifying Geographic Disparities in Diabetes Prevalence Among Adults and Children Using Emergency Claims Data

    Author(s): Lee DC; Gallagher MP; Gopalan A; Osorio M; Vinson AJ; Wall SP; Ravenell JE; Sevick MA; Elbel B

    J Endocr Soc. 2018 May 01;2(5):460-470. Epub 2018-04-17.

    PubMed abstract

    A systematic review of care management interventions targeting multimorbidity and high care utilization

    Author(s): Baker JM; Grant RW; Gopalan A

    BMC Health Serv Res. 2018 01 30;18(1):65. Epub 2018-01-30.

    PubMed abstract

    Population Health Management for Diabetes: Health Care System-Level Approaches for Improving Quality and Addressing Disparities

    Author(s): Schmittdiel JA; Gopalan A; Lin MW; Banerjee S; Chau CV; Adams AS

    Curr Diab Rep. 2017 May;17(5):31.

    PubMed abstract

    Randomised controlled trial of alternative messages to increase enrolment in a healthy food programme among individuals with diabetes

    Author(s): Gopalan A; Paramanund J; Shaw PA; Patel D; Friedman J; Brophy C; Buttenheim AM; Troxel AB; Asch DA; Volpp KG

    BMJ Open. 2016 Nov 30;6(11):e012009. Epub 2016-11-30.

    PubMed abstract

    Health-Specific Information and Communication Technology Use and Its Relationship to Obesity in High-Poverty, Urban Communities: Analysis of a Population-Based Biosocial Survey

    Author(s): Gopalan A; Makelarski JA; Garibay LB; Escamilla V; Merchant RM; Wolfe MB; Holbrook R; Lindau ST

    J Med Internet Res. 2016;18(6):e182. Epub 2016-06-28.

    PubMed abstract